Hikma Pharmaceuticals PLC
OTC: HKMPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Said Samih Taleb Darwazah
- Employees
- 9,500
- Headquarters
- London, United Kingdom
- IPO year
- 2012
- Market cap
- $4.1B
- Website
- https://www.hikma.com
Loading HKMPF…
Loading profile data…Frequently asked questions about HKMPF
What does Hikma Pharmaceuticals PLC (HKMPF) do?
Hikma Pharmaceuticals PLC is a global pharmaceutical firm engaged in the development, manufacturing, commercialization, and distribution of a wide array of medications, including its own branded products, licensed drugs, and generic formulations. These pharmaceutical offerings come in various forms, such as solids, semi-solids, liquids, and inje...
Where does HKMPF trade?
Hikma Pharmaceuticals PLC (HKMPF) trades on the Other OTC.
What sector is HKMPF in?
Hikma Pharmaceuticals PLC (HKMPF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hikma Pharmaceuticals PLC?
Said Samih Taleb Darwazah is the chief executive officer of Hikma Pharmaceuticals PLC (HKMPF).
Where is Hikma Pharmaceuticals PLC headquartered?
Hikma Pharmaceuticals PLC is headquartered in United Kingdom.
Does HKMPF pay a dividend?
Yes — Hikma Pharmaceuticals PLC (HKMPF) paid a trailing twelve-month dividend of USD 0.84 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HKMPF go public?
Hikma Pharmaceuticals PLC (HKMPF) completed its initial public offering in 2012.